Multistate Fungal Meningitis Outbreak Investigation
The Centers for Disease Control and Prevention (CDC), in collaboration with state and local health departments and the Food and Drug Administration (FDA)
, is investigating a multistate outbreak of fungal meningitis and other infections among patients who received contaminated steroid injections. This form of meningitis is not contagious. The investigation also includes fungal infections associated with the injection site, both spinal and peripheral joints, such as a knee, shoulder or ankle. See Current Situation UpdateThis website was last updated August 5, 2013 3:30 PM EST
At-A-Glance
- Status: Ongoing Investigation
- Infection: Fungal
- Facility Type: Outpatient Setting
- Case Count: 749*
- States: 20*
- Deaths: 63*
- Laboratory Results
Patient Guidance
Laboratory Guidance
News Media
- NEW Infographic - learn about the key points and timeline of this outbreakMarch 25, 2013
- Digital Press Kit - CDC Responds to Multistate Meningitis OutbreakOctober 13, 2012
- CDC, FDA, Massachusetts Department of Public Health Joint Telebriefing Updating Investigation of Meningitis OutbreakOctober 11, 2012
- Press Release: Update on Nationwide Meningitis OutbreakOctober 5, 2012
Additional Agencies Involved
- U.S. Food and Drug Administration (FDA)
- Archive of Updates on Fungal Meningitis Outbreak
- Alert – New England Compounding Center Product Recall Information (Commonwealth of Massachusetts)
[PDF - 24KB]
- FDA reports conditions observed at New England Compounding Center facility (FDA Press Release: Oct. 26, 2012)
- FDA announced the voluntary recall of all Ameridose products on October 31, 2012.
.png)
No hay comentarios:
Publicar un comentario